Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
NEW YORK, NY, USA, February 05, 2021 - TG Therapeutics, Inc.
South Africa halts AstraZeneca vaccine after shots fail against new variant
South Africa halts AstraZeneca vaccine after shots fail against new variant
LONDON (Reuters) - South Africa halted Monday’s planned rollout of AstraZeneca’s COVID-19 vaccinations after data showed it gave minimal protection against mild infection from one variant,...
FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations
FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations
ROCKLAND, MA, USA, February 3, 2021 - EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that the US Food and Drug Administration (F...
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study
SAN DIEGO, CA, USA I February 04, 2021 ICrinetics Pharmaceuticals, Inc.
China approves AstraZeneca’s Forxiga for heart failure
China approves AstraZeneca’s Forxiga for heart failure
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s Forxiga (dapagliflozin) for heart failure with reduced ejection fraction (HFrEF) in adult...
Bristol Myers Squibb and The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
Bristol Myers Squibb and The Rockefeller University Announce License Agreement for SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb (NYSE.
Bayer reaches $2 billion deal over future Roundup cancer claims
Bayer reaches $2 billion deal over future Roundup cancer claims
(Reuters) - Bayer AG struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday.
Scientists find promising avenue to restore cognitive function impaired by Alzheimer's disease
Scientists find promising avenue to restore cognitive function impaired by Alzheimer's disease
A team of neuroscientists has identified a potential means to address the loss of cognitive function due to Alzheimer's disease by targeting protein synthesis in mice.
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader
DUBLIN and LONDON, Feb.
Amgen cuts 500 U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital
Amgen cuts 500 U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital
Amgen is cutting 500 jobs, and its U.
Drug metformin can affect breast cancer risk in women with diabetes
Drug metformin can affect breast cancer risk in women with diabetes
In a new study, researchers found that there appears to be no association between type 2 diabetes and developing breast cancer overall.
Horizon Therapeutics to Purchase Viela Bio for $3.1 Billion
Horizon Therapeutics to Purchase Viela Bio for $3.1 Billion
Horizon Therapeutics Plc said it will purchase Viela Bio Inc.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand